Poor immunological recovery among severely immunosuppressed antiretroviral therapy-naïve Ugandans

View/ Open
Date
2013Author
Nanzigu, Sarah
Kiguba, Ronald
Kabanda, Joseph
Mukonzo, Jackson K .
Waako, Paul
Kityo, Cissy
Makumbi, Fred
Metadata
Show full item recordAbstract
With access to antiretroviral therapy (ART) expanding in resource-limited settings, assessing factors related to clinical, immunological, and virological outcomes of ART is of great importance. Even though ART is loosely referred to as a lifelong treatment, clinical, immunological and virological outcome measures differ among patients on highly active ART (HAART), with differences reported within and across cohorts.1–6 Mortality is among the ART-outcome variables that have been studied extensively, and rates of up to 30% have been reported during the first year of treatment in some sub-Saharan settings
Collections
- Medical and Health Sciences [3684]